Published on December 29, 2016
Is there any more news about myeloma coming out of ASH 2016? Mary Windishar interviewed Cynthia Chmielewski, myeloma patient/advocate/mentor, and asked Cindy for her update. Cindy (@myelomateacher) regularly takes to social media to organize her thoughts and keep up to date. Listen as she shares information about immunotherapies and pharmaceuticals aimed at the high-risk patient: KPT-330 (Selinexor), venetoclax (Venclexta) and nelfinavir (Viracept).